复星医药：万邦盐酸胍法辛缓释片获美国FDA批准上市_老虎社区_美港股上老虎

复星医药：万邦盐酸胍法辛缓释片获美国FDA批准上市

复星国际
2024-06-24

近日，由复星医药旗下江苏万邦生化医药集团有限责任公司和Novelstar Pharmaceuticals Inc.合作开发的盐酸胍法辛缓释片（1mg、2mg、3mg、4mg）获美国食品药品监督管理局（FDA）批准。

盐酸胍法辛缓释片用于注意力缺陷多动症（ADHD）治疗，是一种选择性α2A-肾上腺素受体激动剂，能够与前额叶皮层中的受体结合，提高行为抑制力、改善注意力、增强冲动控制等。其临床上适用于治疗儿童及对兴奋剂不适合、不耐受或已显示无效的6-17岁青少年。 $复星国际(00656)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

Roy野野
·2024-06-24
回复
点赞
举报

抱歉，当前请求异常(-1)

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":320215859314920,"tweetId":"320215859314920","gmtCreate":1719207636010,"gmtModify":1719207640785,"author":{"id":4178675676147230,"idStr":"4178675676147230","authorId":4178675676147230,"authorIdStr":"4178675676147230","name":"复星国际","avatar":"https://static.tigerbbs.com/3231df1aa2bf3c97b6bbf10b4ed8a866","vip":5,"userType":5,"introduction":"创新驱动的全球家庭消费产业集团","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":870,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/540c54a46e279e32957ef752a6b65d82","width":"1080","height":"720"}],"coverImages":[{"img":"https://static.tigerbbs.com/540c54a46e279e32957ef752a6b65d82","width":"1080","height":"720"}],"title":"复星医药：万邦盐酸胍法辛缓释片获美国FDA批准上市","html":"<html><head></head><body><img src=\"https://static.tigerbbs.com/540c54a46e279e32957ef752a6b65d82\" tg-width=\"1080\" tg-height=\"720\">\n近日，由复星医药旗下江苏万邦生化医药集团有限责任公司和Novelstar Pharmaceuticals Inc.合作开发的盐酸胍法辛缓释片（1mg、2mg、3mg、4mg）获美国食品药品监督管理局（FDA）批准。\n盐酸胍法辛缓释片用于注意力缺陷多动症（ADHD）治疗，是一种选择性α2A-肾上腺素受体激动剂，能够与前额叶皮层中的受体结合，提高行为抑制力、改善注意力、增强冲动控制等。其临床上适用于治疗儿童及对兴奋剂不适合、不耐受或已显示无效的6-17岁青少年。 <a href=\"https://laohu8.com/S/00656\">$复星国际(00656)$</a> </body></html>","htmlText":"<html><head></head><body><img src=\"https://static.tigerbbs.com/540c54a46e279e32957ef752a6b65d82\" tg-width=\"1080\" tg-height=\"720\">\n近日，由复星医药旗下江苏万邦生化医药集团有限责任公司和Novelstar Pharmaceuticals Inc.合作开发的盐酸胍法辛缓释片（1mg、2mg、3mg、4mg）获美国食品药品监督管理局（FDA）批准。\n盐酸胍法辛缓释片用于注意力缺陷多动症（ADHD）治疗，是一种选择性α2A-肾上腺素受体激动剂，能够与前额叶皮层中的受体结合，提高行为抑制力、改善注意力、增强冲动控制等。其临床上适用于治疗儿童及对兴奋剂不适合、不耐受或已显示无效的6-17岁青少年。 <a href=\"https://laohu8.com/S/00656\">$复星国际(00656)$</a> </body></html>","text":"近日，由复星医药旗下江苏万邦生化医药集团有限责任公司和Novelstar Pharmaceuticals Inc.合作开发的盐酸胍法辛缓释片（1mg、2mg、3mg、4mg）获美国食品药品监督管理局（FDA）批准。 盐酸胍法辛缓释片用于注意力缺陷多动症（ADHD）治疗，是一种选择性α2A-肾上腺素受体激动剂，能够与前额叶皮层中的受体结合，提高行为抑制力、改善注意力、增强冲动控制等。其临床上适用于治疗儿童及对兴奋剂不适合、不耐受或已显示无效的6-17岁青少年。 $复星国际(00656)$","highlighted":1,"essential":1,"paper":2,"likeSize":5,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/320215859314920","repostId":0,"isVote":1,"tweetType":1,"viewCount":25403,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["00656","FOSUY"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":399,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":320235842998520,"commentId":"320235842998520","gmtCreate":1719212525872,"gmtModify":1719212529631,"authorId":4142984412645600,"author":{"id":4142984412645600,"idStr":"4142984412645600","authorId":4142984412645600,"name":"Roy野野","avatar":"https://static.tigerbbs.com/69c787a61127b39c382e8f409c03c577","vip":1,"currentWearingBadge":{"badgeId":"a97bce155cb14045be40c3fe246e8d20-1","templateUuid":"a97bce155cb14045be40c3fe246e8d20","name":"新晋创作者","description":"首次获得精华帖的创作者","bigImgUrl":"https://static.tigerbbs.com/4ce9180a952c61a51c39f70d533b81a7","smallImgUrl":"https://static.tigerbbs.com/f98cf16cf4b858114f7ab9a779f9e6f1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.26","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2005},"crmLevel":1,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":320215859314920,"objectIdStr":"320215859314920","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"[强][强]","text":"[强][强]","html":"[强][强]","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}

复星医药：万邦盐酸胍法辛缓释片获美国FDA批准上市

评论（1）